Quark Pharmaceuticals
About
Quark Pharmaceuticals is a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
- 51 - 100
Details
- Last Funding Type
- Series H
- Last Funding Money Raised
- $13.90M
- Industries
- Biotechnology,Clinical Trials,Genetics,Medical
- Founded date
- Dec 1, 1994
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Founded in 1994, Quark devoted its early years to developing its innovative technology platform for identification of novel functional target genes and proteins, the âBiFARâ technology. The basic concept, patented by Quark, of high throughput gene inactivation combined with microarray detection of the functional genes responsible for the occurrence of phenotypes of interest, was at that time revolutionary. With the advent of siRNA technology, Quark's approach is rapidly becoming the technology of choice for functional studies industry-wide. We have applied our BiFAR platform in gene discovery programs in serious diseases with significant unmet medical needs, often in collaboration with large pharmaceutical partners. Today we are harvesting the fruits of the innovative targets and concepts we identified.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 4, 2008 | Series Unknown | $27M | 1 | — | — | Detail |
| Apr 18, 2008 | Series H | $13.90M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
SBI Asset Management
|
— | Series Unknown |
